- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03257059
Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses (BEGIN)
May 10, 2019 updated by: JeyaKumar Henry
The aim of this study is to determine whether eating breakfast or having no breakfast has subsequent beneficial health effects, specifically in relation to glycemic response throughout the day and postprandial insulin and non-esterified fatty acids (NEFA) responses 6 hours after breakfast/lunch.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This will be a randomised, crossover study with two treatments in total.
1.) Subjects given with breakfast, 2.) Subjects not given breakfast.
Each of the two test visits will last for approximately 9 hour (spanning over 3 days), during which the following will take place: On Day 1, subjects will come to have the continuous glucose monitoring (CGMS) system inserted.
CGMS will be used to measure 24 hour blood glucose concentrations.
On Day 2, an indwelling catheter will be inserted into the ante cubital fossa or forearm vein of one arm and will be kept patent.
One fasting blood sample (baseline; 4 milliliters of venous blood) will be collected.
Participants with breakfast treatment will then consume the test meal within 15 minutes.
Subsequently, blood samples will be taken at 15, 30, 45, 60, 90, 120, 150 and 180 minutes.At time 180 minutes, participants will be given a standardized lunch to be consumed within 30 minutes.
Blood samples will be taken after lunch at 210, 240, 270, 300, 330 and 360 minutes.
On Day 3, subjects will need to come for removal of the CGMS sensor.
Subjects will come to the CNRC again for the 2nd test visit, with at least 3 days wash-out in-between visits.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Chinese males
- BMI above 23.0 kg/m2
- Age between 40-65 years
- Normal blood pressure (<140/90 mmHg)
- Fasting blood glucose of ≥5.6 mmol/L
- Self-reported regular breakfast consumers
Exclusion Criteria:
- Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency
- major chronic disease such as heart disease, cancer or diabetes mellitus
- taking insulin or drugs known to affect glucose metabolism
- Intentionally restrict food intake
- major medical or surgical event requiring hospitalization within the preceding 3 months
- Have taken antibiotics for 3 months before the study period
- Smoking
- Overnight shift workers
- Any known food allergy (eg. anaphylaxis to peanuts)
- Having active Tuberculosis (TB) or currently receiving treatment for TB
- Any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- Being a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
- Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Breakfast
Subject given standardized breakfast (glutinous rice) to test blood glucose response
|
Glutinous rice (75 grams of available carbohydrate)
|
Experimental: No breakfast
Subject not given breakfast to test blood glucose response
|
No food to be served in the morning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic response
Time Frame: 1.5 days
|
Using continuous glucose monitoring system
|
1.5 days
|
Insulin response
Time Frame: 6 hours
|
Postprandial after treatment
|
6 hours
|
Non-esterified fatty acids (NEFA) response
Time Frame: 6 hours
|
Postprandial after treatment
|
6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 25, 2017
Primary Completion (Actual)
March 28, 2019
Study Completion (Actual)
March 28, 2019
Study Registration Dates
First Submitted
August 9, 2017
First Submitted That Met QC Criteria
August 18, 2017
First Posted (Actual)
August 22, 2017
Study Record Updates
Last Update Posted (Actual)
May 13, 2019
Last Update Submitted That Met QC Criteria
May 10, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2017/00537
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Response
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
Glycemic Index Laboratories, IncUniversity of Guelph; Guelph Research and Development Centre, Agriculture and...Completed
-
Purdue UniversityPepsiCo Global R&DCompletedGlycemic Response
-
PepsiCo Global R&DGlycemic Index Laboratories, IncCompleted
-
Nutricia ResearchRecruitingGlycemic ResponseCanada
-
INQUIS Clinical ResearchUniversity of SaskatchewanCompleted
-
PepsiCo Global R&DCompletedGlycemic Response | Insulinemic Response | Subject Hunger ResponseCanada
-
Azienda Ospedaliera Specializzata in Gastroenterologia...CompletedHealthy Subjects | Glycemic Response | Insulinemic ResponseItaly
Clinical Trials on Breakfast
-
Tel Aviv UniversityHospital de Clinicas CaracasCompleted
-
Westlake UniversitySun Yat-sen UniversityActive, not recruiting
-
Tel Aviv UniversityUnknown
-
University of UlmCompleted
-
University of British ColumbiaCompleted
-
Purdue UniversitySuspendedAppetite and General Nutritional DisordersUnited States
-
Westlake UniversityCompleted
-
Texas Tech UniversityPennington Biomedical Research Center; American Egg BoardCompletedDiabetes Mellitus, Type 2 | Insulin ResistanceUnited States
-
Lund UniversityFood for Health Science Centre, Lund UniversityCompleted
-
University of AarhusThe Danish Dairy Research Foundation, DenmarkCompleted